AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- Open
- $76.10
- 52-wk high
- $155.32
- High
- $77.29
- 52-wk low
- $70.98
- Low
- $74.94
- Prev close
- $75.02
Smart money
Earnings
Earnings came in 1.6% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.40B | $2.39B | $2.26B | $2.47B |
| Cost of what it sold | $715.0M | $743.0M | $641.0M | $673.0M |
| Gross profit | $1.69B | $1.64B | $1.62B | $1.79B |
| What it spent | ||||
| Research and development | $170.0M | $199.0M | $180.0M | $173.0M |
| Sales and admin | $579.0M | $619.0M | $588.0M | $592.0M |
| Other operating costs | — | — | $31.0M | $93.0M |
| Total operating expenses | $749.0M | $818.0M | $799.0M | $858.0M |
| What was left | ||||
| Operating profit | $936.0M | $826.0M | $822.0M | $937.0M |
| Interest on debt | $64.0M | $57.0M | $62.0M | $61.0M |
| Profit before tax | $887.0M | $761.0M | $758.0M | $866.0M |
| Tax | $166.0M | $158.0M | $157.0M | $175.0M |
| Net profit | $721.0M | $603.0M | $601.0M | $691.0M |
| EBITDA | $1.07B | $939.0M | $939.0M | $927.0M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
35 / 100
RSI 14
46balanced
20D volatility
41%annualized
52-week range
$70.98$155.32
20D support
News
What the news says
32 articles · 7 days
Coverage leans bearish
Tone of tracked coverage
GE HealthCare names new CFO
Leans bullishAug 19160,631 Shares in Elanco Animal Health Incorporated $ELAN Purchased by First National Bank of Omaha
Leans bullishAug 19Amylyx (AMLX) Climbs to Fresh High as Avexitide Moves Closer to Commercialization
Leans bullishAug 18
